Your browser doesn't support javascript.
loading
Efficacy and Safety of Neoadjuvant Chemoradiation Therapy Administered for 5 Versus 2 Weeks for Resectable and Borderline Resectable Pancreatic Cancer.
Suto, Hironobu; Okano, Keiichi; Oshima, Minoru; Ando, Yasuhisa; Matsukawa, Hiroyuki; Takahashi, Shigeo; Shibata, Toru; Kamada, Hideki; Kobara, Hideki; Tsuji, Akihito; Masaki, Tsutomu; Suzuki, Yasuyuki.
Afiliación
  • Suto H; From the Departments of Gastroenterological Surgery.
  • Okano K; From the Departments of Gastroenterological Surgery.
  • Oshima M; From the Departments of Gastroenterological Surgery.
  • Ando Y; From the Departments of Gastroenterological Surgery.
  • Matsukawa H; From the Departments of Gastroenterological Surgery.
  • Takahashi S; Radiation Oncology.
  • Shibata T; Radiation Oncology.
  • Kamada H; Gastroenterology and Neurology.
  • Kobara H; Gastroenterology and Neurology.
  • Tsuji A; Clinical Oncology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
  • Masaki T; Gastroenterology and Neurology.
  • Suzuki Y; From the Departments of Gastroenterological Surgery.
Pancreas ; 51(3): 269-277, 2022 03 01.
Article en En | MEDLINE | ID: mdl-35584385

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Pancreas Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Pancreas Asunto de la revista: GASTROENTEROLOGIA Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos